Key result
Ultrasound-based AAA screening cuts AAA mortality by ~50%.
Why the study?
Does ultrasound-based AAA screening reduce mortality from AAA in men over 65 years?
Does ultrasound-based AAA screening reduce mortality from AAA in men over 65 years?
Ultrasound-based screening for AAA significantly reduces disease-specific mortality, supporting the implementation of national screening programs.
Supports national AAA screening programs; leaves open need for updated RCTs in contemporary populations.
Abdominal aortic aneurysm (AAA) disease is a condition that affects mainly men over the age of 65 years. The majority of AAAs will remain asymptomatic and therefore undetected. These undetected aneurysms will invariably grow enough for their walls to rupture leading to death in nearly 75% of those affected. Ultrasound-based AAA screening has been shown to reduce the risk of dying of an AAA by half. This significant reduction of mortality offered by a simple and sensitive non-invasive test has prompted the Department of Health to introduce a national AAA screening programme for England and Wales. In this article, the public health risks of AAA disease together with details of the impact of the anticipated national AAA screening programme are discussed.
No takes yet. Share an insight, caveat, or question.
Hany Hafez (2008) conducted a review in Abdominal aortic aneurysm (AAA) disease. Ultrasound-based AAA screening was evaluated on Death from AAA. Ultrasound-based AAA screening reduces the risk of dying from an abdominal aortic aneurysm by half.